Alan Haruo Bryce
Impact in
- Cancer Research top 0.05%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Prostate Cancer Treatment and Research 69
- Prostate Cancer Diagnosis and Treatment 8
-
- Cancer Genomics and Diagnostics 37
- Cancer, Lipids, and Metabolism 7
- Co-authors
- Emmanuel S. Antonarakis (7 shared papers)Aleksandar Sekulić (4 shared papers)Andrea L. McNatty (4 shared papers)Thai Huu Ho (12 shared papers)Christopher Ryan (1 shared paper)Robert A. Kyle (7 shared papers)Angela Dispenzieri (7 shared papers)RAFAEL RICARDO AURELIANO DA FONSECA (4 shared papers)
- Journals
- Cell Reports (12 papers)Cell (10 papers)Annals of Oncology (9 papers)European Urology (8 papers)The Prostate (7 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Alan Haruo Bryce
170 papers receiving 30.8k citations
Alan Haruo Bryce's Hit Papers
Peers
Comparison fields: 5 of 163
- Cancer Research 8.9k
- Oncology 8.7k
- Pulmonary and Respiratory Medicine 8.2k
- Molecular Biology 13.7k
- Immunology 2.7k
Countries citing papers authored by Alan Haruo Bryce
This map shows the geographic impact of Alan Haruo Bryce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Haruo Bryce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Haruo Bryce more than expected).
Fields of papers citing papers by Alan Haruo Bryce
This network shows the impact of papers produced by Alan Haruo Bryce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Haruo Bryce. The network helps show where Alan Haruo Bryce may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Haruo Bryce, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 177 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics Hit paper breakdown → | 2018 | 2602 |
| 2 | The Molecular Taxonomy of Primary Prostate Cancer Hit paper breakdown → | 2015 | 2435 |
| 3 | Oncogenic Signaling Pathways in The Cancer Genome Atlas Hit paper breakdown → | 2018 | 2334 |
| 4 | Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial Hit paper breakdown → | 2015 | 2293 |
| 5 | Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer Hit paper breakdown → | 2018 | 1720 |
| 6 | Comprehensive Characterization of Cancer Driver Genes and Mutations Hit paper breakdown → | 2018 | 1714 |
| 7 | Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation Hit paper breakdown → | 2018 | 1617 |
| 8 | Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA Hit paper breakdown → | 2020 | 1052 |
| 9 | Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas Hit paper breakdown → | 2018 | 810 |
| 10 | Genomic and Functional Approaches to Understanding Cancer Aneuploidy Hit paper breakdown → | 2018 | 749 |
| 11 | Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients Hit paper breakdown → | 2018 | 685 |
| 12 | Pathogenic Germline Variants in 10,389 Adult Cancers Hit paper breakdown → | 2018 | 606 |
| 13 | Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines Hit paper breakdown → | 2018 | 583 |
| 14 | The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma Hit paper breakdown → | 2018 | 569 |
| 15 | Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration Hit paper breakdown → | 2020 | 550 |
| 16 | A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers Hit paper breakdown → | 2018 | 456 |
| 17 | Driver Fusions and Their Implications in the Development and Treatment of Human Cancers Hit paper breakdown → | 2018 | 451 |
| 18 | The Immune Landscape of Cancer Hit paper breakdown → | 2019 | 449 |
| 19 | 2018 | 392 | |
| 20 | Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer Hit paper breakdown → | 2018 | 372 |
About Alan Haruo Bryce
Alan Haruo Bryce is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Molecular Biology and Pathology and Forensic Medicine, having authored 177 papers that have together received 31.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (69 papers), Cancer Genomics and Diagnostics (37 papers), PARP inhibition in cancer therapy (14 papers), Genetic factors in colorectal cancer (9 papers), Cancer Immunotherapy and Biomarkers (9 papers), Radiopharmaceutical Chemistry and Applications (8 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Cancer, Lipids, and Metabolism (7 papers). The work is most often cited by research in Cancer Research (8.9k citations), Oncology (8.7k citations), Pulmonary and Respiratory Medicine (8.2k citations), Molecular Biology (13.7k citations) and Immunology (2.7k citations). Alan Haruo Bryce has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Emmanuel S. Antonarakis, Aleksandar Sekulić, Andrea L. McNatty, Thai Huu Ho, Christopher Ryan, Robert A. Kyle, Angela Dispenzieri, RAFAEL RICARDO AURELIANO DA FONSECA, Morie Abraham Gertz and Nicholas J. Vogelzang. Their work appears in journals such as Cell Reports, Cell, Annals of Oncology, European Urology and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.